News
Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback